These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12228873)

  • 1. Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.
    Green HJ; Pakenham KI; Headley BC; Gardiner RA
    Psychooncology; 2002; 11(5):401-14. PubMed ID: 12228873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.
    Green HJ; Pakenham KI; Headley BC; Yaxley J; Nicol DL; Mactaggart PN; Swanson CE; Watson RB; Gardiner RA
    BJU Int; 2004 May; 93(7):975-9. PubMed ID: 15142146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
    Ulloa EW; Salup R; Patterson SG; Jacobsen PB
    Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional survey of long-term quality of life after radical perineal prostatectomy.
    Yang BK; Crisci A; Young MD; Silverstein AD; Peterson BL; Dahm P
    Urology; 2005 Jan; 65(1):120-5. PubMed ID: 15667876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
    Jenkins VA; Bloomfield DJ; Shilling VM; Edginton TL
    BJU Int; 2005 Jul; 96(1):48-53. PubMed ID: 15963119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
    Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
    BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
    Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
    BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer.
    Sakai H; Igawa T; Tsurusaki T; Yura M; Kusaba Y; Hayashi M; Iwasaki S; Hakariya H; Hara T; Kanetake H
    Urology; 2009 Mar; 73(3):635-40. PubMed ID: 19038426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
    Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
    Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life among patients with metastatic prostate cancer.
    Albertsen PC; Aaronson NK; Muller MJ; Keller SD; Ware JE
    Urology; 1997 Feb; 49(2):207-16; discussion 216-7. PubMed ID: 9037282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the use of histrelin acetate in the treatment of prostate cancer.
    Crawford ED
    BJU Int; 2009 Mar; 103 Suppl 2():14-22. PubMed ID: 19228148
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease-specific symptoms and general quality of life of patients with prostate carcinoma before and after primary three-dimensional conformal radiotherapy.
    Staff I; Salner A; Bohannon R; Panatieri P; Maljanian R
    Cancer; 2003 Dec; 98(11):2335-43. PubMed ID: 14635067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological adjustment of survivors of localised prostate cancer: investigating the role of dyadic adjustment, cognitive appraisal and coping style.
    Wootten AC; Burney S; Foroudi F; Frydenberg M; Coleman G; Ng KT
    Psychooncology; 2007 Nov; 16(11):994-1002. PubMed ID: 17278153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in Dutch men with prostate cancer.
    Voerman B; Fischer M; Visser A; Garssen B; van Andel G; Bensing J
    J Psychosoc Oncol; 2006; 24(2):49-64. PubMed ID: 17046806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer.
    Pinkawa M; Fischedick K; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Urology; 2006 Jul; 68(1):104-9. PubMed ID: 16806434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal comparisons of health-related quality of life between patients with prostate carcinoma and matched controls.
    Hoffman RM; Gilliland FD; Penson DF; Stone SN; Hunt WC; Potosky AL
    Cancer; 2004 Nov; 101(9):2011-9. PubMed ID: 15452835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma.
    Fowler FJ; McNaughton Collins M; Walker Corkery E; Elliott DB; Barry MJ
    Cancer; 2002 Jul; 95(2):287-95. PubMed ID: 12124828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life.
    Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y
    Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.